News

New Scripps Research study offers guidance for more effective Ebola vaccines.

The $75,000 in award funding will support Engle’s work to invent new tools to make new drug candidates quickly, efficiently and sustainably.

"We’re very pleased to have these stellar scientists join our faculty."

"Our study shows an almost threefold improvement in the rate of diagnosis of AFib in the those actively monitored compared to usual care."

There's new evidence that cardiovascular risk factors can be accurately measured and tracked independently outside of a physician’s office using new mobile health technologies.

The researchers estimated that a single human dose of the drugs would convey an insecticide effect against mosquitos and sand flies lasting 50–90 days.

The research offers another approach for tackling diseases that have been considered “undruggable,” including ALS, muscular dystrophy, cystic fibrosis and certain cancers.

"Dr. Sharpless has made numerous contributions to chemistry that have each significantly moved the field forward."

"The big takeaway here is that we have a new molecular target linked to alcohol addiction."

Collaboration will focus on switchable CAR-T therapies aimed primarily at solid tumors.

The work has important implications for understanding how human cancer cells develop resistance to natural product-based chemotherapies. 

Bacteria found in soil may harbor a potential game-changer for drug design. 

The method is likely to be adopted widely for the making of prospective drugs and other chemical products.

Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized ‘miniecosystems’ to quickly see if a molecule can function as a potential therapeutic.

The team found that when the protein that controls the process is defective, in nerve cells in particular, it can allow dangerous, misfolded proteins to accumulate.

Scripps Research is the top stand-alone scientific institute in the United States for producing high-quality research, according to a recently released Nature Index ranking.

Proteins with a selective targeting system can zero in on a protein found on the surface of several types of cancer cells.

“This research further shows that RNA is indeed a viable target to make medicines.”

The grant builds upon previous work from the Rumbaugh lab that uncovered a sensitive period in brain development.

Widely respected for his scientific and business leadership, Martin was named best CEO in 2015 by the investment research company Morningstar. 

Lansing is a co-founder of the Stand Up To Cancer initiative, which funds and facilitates patient-focused, collaborative cancer research.

New study shows the importance of considering local temperature and geography when measuring cardiovascular health.

Amidst a nation-wide opioid epidemic, scientists at The Scripps Research Institute are making strides in developing new, non-opioid pain medications. 

"Until now, most of the research to screen for cancer drugs has used cells that are growing flat on a plate."